Assessment of liver fibrosis in the clinical setting: Something is changing?

Minerva Gastroenterologica e Dietologica

Volumn 53, Issue 1, 2007, Pages 111-114

  Berrutti, M ^a   Ciancio, A ^a   Smedile, A ^a   Brunello, F ^a   Bonardi, R ^a   Pellicano, R ^a   Astegiano, M ^a   Sapone, N ^a   Touscoz, G A ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

FibroScan; Liver diseases; Liver fibrosis

Indexed keywords

DIAGNOSTIC IMAGING; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; LIVER BIOPSY; LIVER FIBROSIS; REVIEW;

HUMANS; LIVER CIRRHOSIS;

EID: 34250810174     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Poynard T, Bedossa P, Opolon P for the OBSVIRC, METAVIR; CLINIVIR and DOSVIR groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
2. Castera L. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Minerva Gastroenterol Dietol 2006;52:125-34.
3. Pinzani M. Liver fibrosis. Springer Semin Immunopathol 1999;21:475-90.
4. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
5. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
6. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
7. Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. Gut 1999;45 Suppl 4: IV1-IV11.
8. Regev A, Berho M, Jeffers LJ, Minkowski C, Molina EG, Pyrsopoulos NT et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-8.
9. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139:667-9.
10. Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006;12:3682-94.
11. Ganne-Carriè N, Ziol M, De Ledinghen V, Douvin C, Marcellin P, Castera L et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-7.
12. Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-8.
13. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.
14. Gómez-Dómínguez E, Mendoza J, Rubio S, Moreno-Monteagudo JA, García-Buey L, Moreno-Otero R. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006;24:513-8.
15. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007 Jan 25; [Epub ahead of print].